BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 8712293)

  • 1. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].
    Yang WT; Xu YX; Zhang TQ
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):594-7. PubMed ID: 17134566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
    Ding HY; Gao LX
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
    Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
    Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary endocrine ductal carcinoma in situ: a case report.
    Danikas D; Matthews WE; Averbach DJ
    Am Surg; 2000 Dec; 66(12):1163-4. PubMed ID: 11149590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases.
    Kawasaki T; Nakamura S; Sakamoto G; Murata S; Tsunoda-Shimizu H; Suzuki K; Takahashi O; Nakazawa T; Kondo T; Katoh R
    Histopathology; 2008 Sep; 53(3):288-98. PubMed ID: 18657193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
    Moriya T; Silverberg SG
    Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade cribriform ductal carcinoma in situ of the breast. Fine needle aspiration cytology in three cases.
    Lilleng R; Hagmar BM; Farrants G
    Acta Cytol; 1992; 36(1):48-54. PubMed ID: 1312285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast.
    Raju U; Crissman JD; Zarbo RJ; Gottlieb C
    Am J Surg Pathol; 1990 Oct; 14(10):939-47. PubMed ID: 1698341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
    Kelten Talu C; Savli TC; Huq GE; Leblebici C
    Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular adenosis of the breast. A distinctive benign lesion mimicking invasive carcinoma.
    Lee KC; Chan JK; Gwi E
    Am J Surg Pathol; 1996 Jan; 20(1):46-54. PubMed ID: 8540608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
    Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
    Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S
    Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-needle aspiration cytology of breast carcinoma with endocrine differentiation.
    Tse GM; Ma TK
    Cancer; 2000 Oct; 90(5):286-91. PubMed ID: 11038425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructure of the periductal area of comedo carcinoma in situ of the breast.
    Tang P; Teichberg S; Roberts B; Hajdu SI
    Ann Clin Lab Sci; 2001 Jul; 31(3):284-90. PubMed ID: 11508833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.
    Bellamy CO; McDonald C; Salter DM; Chetty U; Anderson TJ
    Hum Pathol; 1993 Jan; 24(1):16-23. PubMed ID: 8380275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
    Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
    J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous bilateral neuroendocrine ductal carcinoma in situ.
    Honami H; Sotome K; Sakamoto G; Iri H; Tanaka Y; Fukamachi S; Morozumi K
    Breast Cancer; 2014 Jul; 21(4):508-13. PubMed ID: 21735237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.